APO Research
Talk to an analyst

APO RESEARCH · REPORT

Primidone

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Primidone Market Outlook and Growth Opportunities 2026

19 December 2025194 pages

Choose your research edition.

Industry ResearchPrimidone Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Primidone Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Primidone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Primidone Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Primidone Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Primidone market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Primidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Primidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Primidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Primidone market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Primidone market include Amneal Pharm, Anda Repository, Dr Reddys Laboratories, Hikma Intl Pharms, Impax Laboratories, Lannett, Mutual Pharmaceutical, Oxford Pharms and Valeant, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Primidone market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Primidone and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Primidone sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Primidone market size, projected growth trends, production technologies, key applications, and end-use industries.

Primidone Segment by Company

Amneal Pharm

Anda Repository

Dr Reddys Laboratories

Hikma Intl Pharms

Impax Laboratories

Lannett

Mutual Pharmaceutical

Oxford Pharms

Valeant

Valeant Pharmaceuticals International

Vintage Pharmaceuticals

Watson Labs

West Ward Pharmaceutical

Xcel Pharmaceuticals

Primidone Segment by Type

50mg

250mg

Primidone Segment by Application

Epilepsy

Psychiatric Disorders

Essential Tremor

Primidone Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Primidone status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Primidone market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Primidone significant trends, drivers, influence factors in global and regions.

6. To analyze Primidone competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Primidone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Primidone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Primidone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Primidone market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Primidone industry.

Chapter 3: Detailed analysis of Primidone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Primidone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Primidone in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Primidone Industry Trends Table 2. Primidone Industry Drivers Table 3. Primidone Industry Opportunities and Challenges Table 4. Primidone Industry Restraints Table 5. Global Primidone Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Primidone Revenue Share by Company (2021-2026) Table 7. Global Primidone Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Primidone Sales Volume Share by Company (2021-2026) Table 9. Global Primidone Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Primidone Company Ranking, (2024-2026) & (USD Million) Table 11. Global Primidone Key Company Manufacturing Base & Headquarters Table 12. Global Primidone Company, Product Type & Application Table 13. Global Primidone Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Primidone by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 50mg Table 18. Significant Companies of 250mg Table 19. Global Primidone Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Primidone Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Primidone Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Primidone Sales Volume Share by Type (2021-2026) Table 23. Global Primidone Sales Volume Share by Type (2027-2032) Table 24. Global Primidone Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Primidone Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Primidone Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Primidone Sales Value Share by Type (2021-2026) Table 28. Global Primidone Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Epilepsy Table 30. Significant Companies of Psychiatric Disorders Table 31. Significant Companies of Essential Tremor Table 32. Global Primidone Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Primidone Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Primidone Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Primidone Sales Volume Share by Application (2021-2026) Table 36. Global Primidone Sales Volume Share by Application (2027-2032) Table 37. Global Primidone Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Primidone Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Primidone Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Primidone Sales Value Share by Application (2021-2026) Table 41. Global Primidone Sales Value Share by Application (2027-2032) Table 42. Global Primidone Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Primidone Sales by Region (2021-2026) & (K Units) Table 44. Global Primidone Sales Market Share by Region (2021-2026) Table 45. Global Primidone Sales by Region (2027-2032) & (K Units) Table 46. Global Primidone Sales Market Share by Region (2027-2032) Table 47. Global Primidone Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Primidone Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Primidone Sales Value Share by Region (2021-2026) Table 50. Global Primidone Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Primidone Sales Value Share by Region (2027-2032) Table 52. Global Primidone Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Primidone Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Primidone Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Primidone Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Primidone Sales by Country (2021-2026) & (K Units) Table 57. Global Primidone Sales Market Share by Country (2021-2026) Table 58. Global Primidone Sales by Country (2027-2032) & (K Units) Table 59. Global Primidone Sales Market Share by Country (2027-2032) Table 60. Global Primidone Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Primidone Sales Value Market Share by Country (2021-2026) Table 62. Global Primidone Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Primidone Sales Value Market Share by Country (2027-2032) Table 64. Amneal Pharm Company Information Table 65. Amneal Pharm Business Overview Table 66. Amneal Pharm Primidone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Amneal Pharm Primidone Product Portfolio Table 68. Amneal Pharm Recent Development Table 69. Anda Repository Company Information Table 70. Anda Repository Business Overview Table 71. Anda Repository Primidone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Anda Repository Primidone Product Portfolio Table 73. Anda Repository Recent Development Table 74. Dr Reddys Laboratories Company Information Table 75. Dr Reddys Laboratories Business Overview Table 76. Dr Reddys Laboratories Primidone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Dr Reddys Laboratories Primidone Product Portfolio Table 78. Dr Reddys Laboratories Recent Development Table 79. Hikma Intl Pharms Company Information Table 80. Hikma Intl Pharms Business Overview Table 81. Hikma Intl Pharms Primidone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Hikma Intl Pharms Primidone Product Portfolio Table 83. Hikma Intl Pharms Recent Development Table 84. Impax Laboratories Company Information Table 85. Impax Laboratories Business Overview Table 86. Impax Laboratories Primidone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Impax Laboratories Primidone Product Portfolio Table 88. Impax Laboratories Recent Development Table 89. Lannett Company Information Table 90. Lannett Business Overview Table 91. Lannett Primidone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Lannett Primidone Product Portfolio Table 93. Lannett Recent Development Table 94. Mutual Pharmaceutical Company Information Table 95. Mutual Pharmaceutical Business Overview Table 96. Mutual Pharmaceutical Primidone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Mutual Pharmaceutical Primidone Product Portfolio Table 98. Mutual Pharmaceutical Recent Development Table 99. Oxford Pharms Company Information Table 100. Oxford Pharms Business Overview Table 101. Oxford Pharms Primidone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Oxford Pharms Primidone Product Portfolio Table 103. Oxford Pharms Recent Development Table 104. Valeant Company Information Table 105. Valeant Business Overview Table 106. Valeant Primidone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Valeant Primidone Product Portfolio Table 108. Valeant Recent Development Table 109. Valeant Pharmaceuticals International Company Information Table 110. Valeant Pharmaceuticals International Business Overview Table 111. Valeant Pharmaceuticals International Primidone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Valeant Pharmaceuticals International Primidone Product Portfolio Table 113. Valeant Pharmaceuticals International Recent Development Table 114. Vintage Pharmaceuticals Company Information Table 115. Vintage Pharmaceuticals Business Overview Table 116. Vintage Pharmaceuticals Primidone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Vintage Pharmaceuticals Primidone Product Portfolio Table 118. Vintage Pharmaceuticals Recent Development Table 119. Watson Labs Company Information Table 120. Watson Labs Business Overview Table 121. Watson Labs Primidone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Watson Labs Primidone Product Portfolio Table 123. Watson Labs Recent Development Table 124. West Ward Pharmaceutical Company Information Table 125. West Ward Pharmaceutical Business Overview Table 126. West Ward Pharmaceutical Primidone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. West Ward Pharmaceutical Primidone Product Portfolio Table 128. West Ward Pharmaceutical Recent Development Table 129. Xcel Pharmaceuticals Company Information Table 130. Xcel Pharmaceuticals Business Overview Table 131. Xcel Pharmaceuticals Primidone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Xcel Pharmaceuticals Primidone Product Portfolio Table 133. Xcel Pharmaceuticals Recent Development Table 134. Key Raw Materials Table 135. Raw Materials Key Suppliers Table 136. Primidone Distributors List Table 137. Primidone Customers List Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources Table 141. Primary Sources List of Figures Figure 1. Primidone Product Image Figure 2. Global Primidone Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Primidone Sales Value (2021-2032) & (US$ Million) Figure 4. Global Primidone Sales (2021-2032) & (K Units) Figure 5. Global Primidone Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Primidone Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 50mg Image Figure 10. 250mg Image Figure 11. Global Primidone Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Primidone Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Primidone Sales Volume Share by Type (2021-2032) Figure 14. Global Primidone Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Primidone Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Primidone Sales Value Share by Type (2021-2032) Figure 17. Epilepsy Image Figure 18. Psychiatric Disorders Image Figure 19. Essential Tremor Image Figure 20. Global Primidone Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Primidone Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Primidone Sales Volume Share by Application (2021-2032) Figure 23. Global Primidone Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Primidone Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Primidone Sales Value Share by Application (2021-2032) Figure 26. Global Primidone Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Primidone Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Primidone Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Primidone Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Primidone Sales Value (2021-2032) & (US$ Million) Figure 31. North America Primidone Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Primidone Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Primidone Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Primidone Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Primidone Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Primidone Sales Value (2021-2032) & (US$ Million) Figure 37. South America Primidone Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Primidone Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Primidone Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Primidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Primidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Primidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Primidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Primidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Primidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Primidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Primidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Primidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Primidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Primidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Primidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Primidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Primidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Primidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Primidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Primidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Primidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Primidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Primidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Primidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Primidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Primidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Primidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Primidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Primidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Primidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Primidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Primidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Primidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Primidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Primidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Primidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Primidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Primidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Primidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Primidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Primidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Primidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Primidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Primidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Primidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Primidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Primidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Primidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Primidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Primidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Primidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Primidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Primidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Primidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Primidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Primidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Primidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Primidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Primidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Primidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Primidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Primidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Primidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Primidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Primidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Primidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Primidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Primidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Primidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Primidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Primidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Primidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Primidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Primidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Primidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Primidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Primidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Primidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Primidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Primidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Primidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Primidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Primidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Primidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Primidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Primidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Primidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Primidone Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Primidone Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 50mg
  • 250mg
Applications
  • Epilepsy
  • Psychiatric Disorders
  • Essential Tremor
Companies covered
  • Amneal Pharm
  • Anda Repository
  • Dr Reddys Laboratories
  • Hikma Intl Pharms
  • Impax Laboratories
  • Lannett
  • Mutual Pharmaceutical
  • Oxford Pharms
  • Valeant
  • Valeant Pharmaceuticals International
  • Vintage Pharmaceuticals
  • Watson Labs
  • West Ward Pharmaceutical
  • Xcel Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Primidone Sales Value (2021-2032)
  4. 1.2.2 Global Primidone Sales Volume (2021-2032)
  5. 1.2.3 Global Primidone Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Primidone Market Dynamics
  1. 2.1 Primidone Industry Trends
  2. 2.2 Primidone Industry Drivers
  3. 2.3 Primidone Industry Opportunities and Challenges
  4. 2.4 Primidone Industry Restraints
3 Primidone Market by Company
  1. 3.1 Global Primidone Company Revenue Ranking in 2025
  2. 3.2 Global Primidone Revenue by Company (2021-2026)
  3. 3.3 Global Primidone Sales Volume by Company (2021-2026)
  4. 3.4 Global Primidone Average Price by Company (2021-2026)
  5. 3.5 Global Primidone Company Ranking (2024-2026)
  6. 3.6 Global Primidone Company Manufacturing Base and Headquarters
  7. 3.7 Global Primidone Company Product Type and Application
  8. 3.8 Global Primidone Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Primidone Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Primidone Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Primidone Market by Type
  1. 4.1 Primidone Type Introduction
  2. 4.1.1 50mg
  3. 4.1.2 250mg
  4. 4.2 Global Primidone Sales Volume by Type
  5. 4.2.1 Global Primidone Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Primidone Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Primidone Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Primidone Sales Value by Type
  9. 4.3.1 Global Primidone Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Primidone Sales Value by Type (2021-2032)
  11. 4.3.3 Global Primidone Sales Value Share by Type (2021-2032)
5 Primidone Market by Application
  1. 5.1 Primidone Application Introduction
  2. 5.1.1 Epilepsy
  3. 5.1.2 Psychiatric Disorders
  4. 5.1.3 Essential Tremor
  5. 5.2 Global Primidone Sales Volume by Application
  6. 5.2.1 Global Primidone Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Primidone Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Primidone Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Primidone Sales Value by Application
  10. 5.3.1 Global Primidone Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Primidone Sales Value by Application (2021-2032)
  12. 5.3.3 Global Primidone Sales Value Share by Application (2021-2032)
6 Primidone Regional Sales and Value Analysis
  1. 6.1 Global Primidone Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Primidone Sales by Region (2021-2032)
  3. 6.2.1 Global Primidone Sales by Region: 2021-2026
  4. 6.2.2 Global Primidone Sales by Region (2027-2032)
  5. 6.3 Global Primidone Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Primidone Sales Value by Region (2021-2032)
  7. 6.4.1 Global Primidone Sales Value by Region: 2021-2026
  8. 6.4.2 Global Primidone Sales Value by Region (2027-2032)
  9. 6.5 Global Primidone Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Primidone Sales Value (2021-2032)
  12. 6.6.2 North America Primidone Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Primidone Sales Value (2021-2032)
  15. 6.7.2 Europe Primidone Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Primidone Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Primidone Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Primidone Sales Value (2021-2032)
  21. 6.9.2 South America Primidone Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Primidone Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Primidone Sales Value Share by Country, 2025 VS 2032
7 Primidone Country-level Sales and Value Analysis
  1. 7.1 Global Primidone Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Primidone Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Primidone Sales by Country (2021-2032)
  4. 7.3.1 Global Primidone Sales by Country (2021-2026)
  5. 7.3.2 Global Primidone Sales by Country (2027-2032)
  6. 7.4 Global Primidone Sales Value by Country (2021-2032)
  7. 7.4.1 Global Primidone Sales Value by Country (2021-2026)
  8. 7.4.2 Global Primidone Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Primidone Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Primidone Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Primidone Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Primidone Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Primidone Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Primidone Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Primidone Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Primidone Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Primidone Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Primidone Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Primidone Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Primidone Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Primidone Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Primidone Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Primidone Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Primidone Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Primidone Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Primidone Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Primidone Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Primidone Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Primidone Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Primidone Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Primidone Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Primidone Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Primidone Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Primidone Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Primidone Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Primidone Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Primidone Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Primidone Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Primidone Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Primidone Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Primidone Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Primidone Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Primidone Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Primidone Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Primidone Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Primidone Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Primidone Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Primidone Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Primidone Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Primidone Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Primidone Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Primidone Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Primidone Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Primidone Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Primidone Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Primidone Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Primidone Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Primidone Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Primidone Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Primidone Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Primidone Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Primidone Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Primidone Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Primidone Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Primidone Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Primidone Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Primidone Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Primidone Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Primidone Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Primidone Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Primidone Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Primidone Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Primidone Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Primidone Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Primidone Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Primidone Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Primidone Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Primidone Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Primidone Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Primidone Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Primidone Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Primidone Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Primidone Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Primidone Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Primidone Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Primidone Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Primidone Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Primidone Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Primidone Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Primidone Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Primidone Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Primidone Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Amneal Pharm
  2. 8.1.1 Amneal Pharm Company Information
  3. 8.1.2 Amneal Pharm Business Overview
  4. 8.1.3 Amneal Pharm Primidone Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Amneal Pharm Primidone Product Portfolio
  6. 8.1.5 Amneal Pharm Recent Developments
  7. 8.2 Anda Repository
  8. 8.2.1 Anda Repository Company Information
  9. 8.2.2 Anda Repository Business Overview
  10. 8.2.3 Anda Repository Primidone Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Anda Repository Primidone Product Portfolio
  12. 8.2.5 Anda Repository Recent Developments
  13. 8.3 Dr Reddys Laboratories
  14. 8.3.1 Dr Reddys Laboratories Company Information
  15. 8.3.2 Dr Reddys Laboratories Business Overview
  16. 8.3.3 Dr Reddys Laboratories Primidone Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Dr Reddys Laboratories Primidone Product Portfolio
  18. 8.3.5 Dr Reddys Laboratories Recent Developments
  19. 8.4 Hikma Intl Pharms
  20. 8.4.1 Hikma Intl Pharms Company Information
  21. 8.4.2 Hikma Intl Pharms Business Overview
  22. 8.4.3 Hikma Intl Pharms Primidone Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Hikma Intl Pharms Primidone Product Portfolio
  24. 8.4.5 Hikma Intl Pharms Recent Developments
  25. 8.5 Impax Laboratories
  26. 8.5.1 Impax Laboratories Company Information
  27. 8.5.2 Impax Laboratories Business Overview
  28. 8.5.3 Impax Laboratories Primidone Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Impax Laboratories Primidone Product Portfolio
  30. 8.5.5 Impax Laboratories Recent Developments
  31. 8.6 Lannett
  32. 8.6.1 Lannett Company Information
  33. 8.6.2 Lannett Business Overview
  34. 8.6.3 Lannett Primidone Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Lannett Primidone Product Portfolio
  36. 8.6.5 Lannett Recent Developments
  37. 8.7 Mutual Pharmaceutical
  38. 8.7.1 Mutual Pharmaceutical Company Information
  39. 8.7.2 Mutual Pharmaceutical Business Overview
  40. 8.7.3 Mutual Pharmaceutical Primidone Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Mutual Pharmaceutical Primidone Product Portfolio
  42. 8.7.5 Mutual Pharmaceutical Recent Developments
  43. 8.8 Oxford Pharms
  44. 8.8.1 Oxford Pharms Company Information
  45. 8.8.2 Oxford Pharms Business Overview
  46. 8.8.3 Oxford Pharms Primidone Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Oxford Pharms Primidone Product Portfolio
  48. 8.8.5 Oxford Pharms Recent Developments
  49. 8.9 Valeant
  50. 8.9.1 Valeant Company Information
  51. 8.9.2 Valeant Business Overview
  52. 8.9.3 Valeant Primidone Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Valeant Primidone Product Portfolio
  54. 8.9.5 Valeant Recent Developments
  55. 8.10 Valeant Pharmaceuticals International
  56. 8.10.1 Valeant Pharmaceuticals International Company Information
  57. 8.10.2 Valeant Pharmaceuticals International Business Overview
  58. 8.10.3 Valeant Pharmaceuticals International Primidone Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Valeant Pharmaceuticals International Primidone Product Portfolio
  60. 8.10.5 Valeant Pharmaceuticals International Recent Developments
  61. 8.11 Vintage Pharmaceuticals
  62. 8.11.1 Vintage Pharmaceuticals Company Information
  63. 8.11.2 Vintage Pharmaceuticals Business Overview
  64. 8.11.3 Vintage Pharmaceuticals Primidone Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Vintage Pharmaceuticals Primidone Product Portfolio
  66. 8.11.5 Vintage Pharmaceuticals Recent Developments
  67. 8.12 Watson Labs
  68. 8.12.1 Watson Labs Company Information
  69. 8.12.2 Watson Labs Business Overview
  70. 8.12.3 Watson Labs Primidone Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Watson Labs Primidone Product Portfolio
  72. 8.12.5 Watson Labs Recent Developments
  73. 8.13 West Ward Pharmaceutical
  74. 8.13.1 West Ward Pharmaceutical Company Information
  75. 8.13.2 West Ward Pharmaceutical Business Overview
  76. 8.13.3 West Ward Pharmaceutical Primidone Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 West Ward Pharmaceutical Primidone Product Portfolio
  78. 8.13.5 West Ward Pharmaceutical Recent Developments
  79. 8.14 Xcel Pharmaceuticals
  80. 8.14.1 Xcel Pharmaceuticals Company Information
  81. 8.14.2 Xcel Pharmaceuticals Business Overview
  82. 8.14.3 Xcel Pharmaceuticals Primidone Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Xcel Pharmaceuticals Primidone Product Portfolio
  84. 8.14.5 Xcel Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Primidone Value Chain Analysis
  2. 9.1.1 Primidone Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Primidone Sales Mode & Process
  6. 9.2 Primidone Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Primidone Distributors
  9. 9.2.3 Primidone Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst